跳到主要內容

Knaster Alexander M 的 Form 4 申報

Privia Health Group, Inc.(PRVA),2021/11/26 申報

申報編號
0000905718-21-001539
申報時間
2021/11/26 13:15 ET
交易日
2021/11/23
申報延遲
3 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 1 筆非衍生性交易。公開市場賣出合計 $4,961 萬。交易後 3 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Knaster Alexander MCIK 0001308574持股 10% 以上大股東
Pamplona Capital Management, LLCCIK 0001554913持股 10% 以上大股東
Pamplona Capital Partners III, L.P.CIK 0001554914持股 10% 以上大股東
Pamplona Capital Management, LLPCIK 0001554942持股 10% 以上大股東
Pamplona PE Investments Malta LtdCIK 0001650903持股 10% 以上大股東
Halsted John C.CIK 0001844403持股 10% 以上大股東
Pamplona Equity Advisors III LtdCIK 0001859731持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/11/23Common StockS賣出處分−1,791,175$27.70F2−$49,606,591.6320,019,808間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), and in connection with the public offering of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the Company, the Company sold 6,000,000 shares (excluding 900,000 additional shares which the underwriters have the right to purchase) of Common Stock pursuant to the final prospectus filed by the Company on November 16, 2021, which offering was consummated on November 23, 2021 (the "Public Offering"). The amount above represents the $30.62 public maximum offering price per share of Common Stock in the Public Offering less the effective public offering discount and underwriting discount of $2.93 per share of Common Stock. The shares sold were held by a private investor group, which includes Pamplona Capital Partners III, L.P.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)